These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36120106)

  • 41. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
    Urbanik LA; Acharya NK; Grigson PS
    Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction.
    Pantazis CB; Gonzalez LA; Tunstall BJ; Carmack SA; Koob GF; Vendruscolo LF
    Sci Adv; 2021 Apr; 7(15):. PubMed ID: 33827822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study.
    Dunn KE; Brands B; Marsh DC; Bigelow GE
    Psychopharmacology (Berl); 2018 Apr; 235(4):971-981. PubMed ID: 29270641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NEURONAL CORRELATES OF HYPERALGESIA AND SOMATIC SIGNS OF HEROIN WITHDRAWAL IN MALE AND FEMALE MICE.
    Alvarez-Bagnarol Y; Marchette RCN; Francis C; Morales MM; Vendruscolo LF
    eNeuro; 2022 Jun; 9(4):. PubMed ID: 35728954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice.
    Zhan J; Jordan CJ; Bi GH; He XH; Gardner EL; Wang YL; Xi ZX
    Neuropharmacology; 2018 Oct; 141():11-20. PubMed ID: 30138692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional signatures of heroin intake and seeking throughout the brain reward circuit.
    Browne CJ; Futamura R; Minier-Toribio A; Hicks EM; Ramakrishnan A; Martínez-Rivera F; Estill M; Godino A; Parise EM; Torres-Berrío A; Cunningham AM; Hamilton PJ; Walker DM; Huckins LM; Hurd YL; Shen L; Nestler EJ
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy.
    Tsai TY; Wang TY; Liu YC; Lee PW; Chang WH; Lu TH; Tseng HH; Lee SY; Chang YH; Yang Y; Chen PS; Chen KC; Yang YK; Lu RB
    Am J Drug Alcohol Abuse; 2021 May; 47(3):330-343. PubMed ID: 33426970
    [No Abstract]   [Full Text] [Related]  

  • 49. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder.
    Pytell JD; Sklar MD; Carrese J; Rastegar DA; Gunn C; Chander G
    J Gen Intern Med; 2022 Feb; 37(3):593-600. PubMed ID: 34027611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment utilization among persons with opioid use disorder in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
    Alexander GC; Ballreich J; Mansour O; Dowdy DW
    Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulation of emotional response in current and abstinent heroin users: negative heightening and positive blunting.
    Aguilar de Arcos F; Verdejo-García A; Ceverino A; Montañez-Pareja M; López-Juárez E; Sánchez-Barrera M; López-Jiménez A; Pérez-García M;
    Psychopharmacology (Berl); 2008 Jun; 198(2):159-66. PubMed ID: 18330545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Mobile Health App to Support Patients Receiving Medication-Assisted Treatment for Opioid Use Disorder: Development and Feasibility Study.
    Waselewski ME; Flickinger TE; Canan C; Harrington W; Franklin T; Otero KN; Huynh J; Waldman ALD; Hilgart M; Ingersoll K; Ait-Daoud Tiouririne N; Dillingham RA
    JMIR Form Res; 2021 Feb; 5(2):e24561. PubMed ID: 33620324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypogonadism in opioid using males in an inner-city cohort: A cross-sectional study.
    Wehbeh L; Dobs AS; Brown TT
    J Opioid Manag; 2021; 17(2):135-144. PubMed ID: 33890277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.
    Lalanne L; Ayranci G; Filliol D; Gavériaux-Ruff C; Befort K; Kieffer BL; Lutz PE
    Addict Biol; 2017 Jul; 22(4):1010-1021. PubMed ID: 27001273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of the categorization process among patients with eating disorders: a new cognitive approach to psychopathology].
    Urdapilleta I; Mirabel-Sarron C; Meunier JM; Richard JF
    Encephale; 2005; 31(1 Pt 1):82-91. PubMed ID: 15971644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.
    Sheynin J; Moustafa AA; Beck KD; Servatius RJ; Casbolt PA; Haber P; Elsayed M; Hogarth L; Myers CE
    J Clin Psychiatry; 2016 Mar; 77(3):386-94. PubMed ID: 27046310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence.
    Wakeman SE; Chang Y; Regan S; Yu L; Flood J; Metlay J; Rigotti N
    J Addict Med; 2019; 13(4):253-257. PubMed ID: 30550392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users.
    Karakula SL; Weiss RD; Griffin ML; Borges AM; Bailey AJ; McHugh RK
    Drug Alcohol Depend; 2016 Dec; 169():68-72. PubMed ID: 27776247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
    Lutz PE; Ayranci G; Chu-Sin-Chung P; Matifas A; Koebel P; Filliol D; Befort K; Ouagazzal AM; Kieffer BL
    Neuropsychopharmacology; 2014 Oct; 39(11):2694-705. PubMed ID: 24874714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.